Quantification of clonal hematopoiesis in polycythemia vera

Virchows Archiv

Volumn 447, Issue 6, 2005, Pages 947-953

  Siebolts, Udo ^a   Ates, Murat ^a   Spitz, Rüdiger ^a   Thiele, Jürgen ^a   Wickenhauser, Claudia ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

CD34+; CGH; Chromosomal aberrations; FISH; Polycythemia vera

Indexed keywords

ADULT; AGED; ARTICLE; BONE MARROW BIOPSY; CD34 SELECTION; CELL FRACTIONATION; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HEMATOPOIESIS; HUMAN; MALE; PARTIAL TRISOMY 9; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYCYTHEMIA VERA; PRIORITY JOURNAL; STEM CELL; TRISOMY 8;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD4; CHROMOSOME ABERRATIONS; CLONE CELLS; HEMATOPOIETIC STEM CELLS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION; POLYCYTHEMIA VERA; SENSITIVITY AND SPECIFICITY;

EID: 28344438065     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-005-0047-7     Document Type: Article

References (31)

1. Amiel A, Gaber E, Manor Y, Fejgin M, Joseph-Lerner N, Ravid M, Lishner M (1995) Fluorescence in situ hybridization for the detection of trisomies 8 and 9 in polycythemia vera. Cancer Genet Cytogenet 79:153-156
2. Baxter EJ, Scott LM, Campbell PJ, East C, Fourouclas N, Swanton S, Vassiliou GS, Bench AJ, Boyd EM, Curtin N, Scott MA, Erber WN, Green AR (2005) Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet 365:1054-1061
3. Bench AJ, Nacheva EP, Champion KM, Green AR (1998) Molecular genetics and cytogenetics of myeloproliferative disorders. Bailliere's Clin Haematol 11:819-848
4. Bhatia R, McGlave PB, Dewald GW, Blazar BR, Verfaillie CM (1995) Abnormal function of the bone marrow microenvironment in chronic myelogenous leukemia: role of malignant stromal macrophages. Blood 85:3636-3645
5. Busson M, Romana S, Khac FN, Bernard O, Berger R (2004) Cryptic translocations involving chromosome 20 in polycythemia vera. Ann Genet 47:365-371
6. Carneskog J, Kutti J, Wadenvik H, Lundberg PA, Lindstedt G (1998) Plasma erythropoietin by high-detectability immunoradiometric assay in untreated and treated patients with polycythaemia vera and essential thrombocythaemia. Eur J Haematol 60:278-282
7. Cashman J, Henkelman D, Humphries K, Eaves C, Eaves A (1983) Individual BFU-E in polycythemia vera produce both erythropoietin dependent and independent progeny. Blood 61:876-884
8. Champion KM, Gilbert JG, Asimakopoulos FA, Hinshelwood S, Green AR (1997) Clonal haemopoiesis in normal elderly women: implications for the myeloproliferative disorders and myelodysplastic syndromes. Br J Haematol 97:920-926
9. Florensa L, Besses C, Zamora L, Bellosillo B, Espinet B, Serrano S, Woessner S, Sole F (2004) Endogenous erythroid and megakaryocytic circulating progenitors, HUMARA clonality assay, and PRV-1 expression are useful tools for diagnosis of polycythemia vera and essential thrombocythemia. Blood 103:2427-2428
10. Gale RE, Fielding AK, Harrison CN, Linch DC (1997) Acquired skewing of X-chromosome inactivation patterns in myeloid cells of the elderly suggests stochastic clonal loss with age. Br J Haematol 98:512-519
11. Gilbert HL, Acharya J, Pearson TC (1998) Implications for the use of X-chromosome inactivation patterns and their relevance to the myeloproliferative disorders. Eur J Haematol 61:282-283
12. Goldman JM (2005) A unifying mutation in chronic myeloproliferative disorders. N Engl J Med 352:1744-1746
13. Herishanu Y, Lishner M, Bomstein Y, Kitay-Cohen Y, Fejgin MD, Gaber E, Amiel A (2001) Comparative genomic hybridization in polycythemia vera and essential thrombocytosis patients. Cancer Genet Cytogenet 128:154-157
14. James C, Ugo V, Le Couedic JP, Staerk J, Delhommeau F, Lacout C, Garcon L, Raslova H, Berger R, Bennaceur-Griscelli A, Villeval JL, Constantinescu SN, Casadevall N, Vainchenker W (2005) A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature 434:1144-1148
15. Jones AV, Kreil S, Zoi K, Waghorn K, Curtis C, Zhang L, Score J, Seear R, Chase AJ, Grand FH, White H, Zoi C, Loukopoulos D, Terpos E, Vervessou EC, Schultheis B, Emig M, Ernst T, Lengfelder E, Hehlmann R, Hochhaus A, Oscier D, Silver RT, Reiter A, Cross NC (2005) Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders. Blood [Epub ahead of print]
16. Kaushansky K (2005) On the molecular origins of the chronic myeloproliferative disorders: it all makes sense. Blood 105:4187-4190
17. Knuutila S, Armengol G, Bjorkqvist AM, el-Rifai W, Larramendy ML, Monni O, Szymanska J (1998) Comparative genomic hybridization study on pooled DNAs from tumors of one clinical-pathological entity. Cancer Genet Cytogenet 100:25-30
18. Kralovics R, Buser AS, Teo SS, Coers J, Tichelli A, van der Maas AP, Skoda RC (2003) Comparison of molecular markers in a cohort of patients with chronic myeloproliferative disorders. Blood 102:1869-1871
19. Kralovics R, Passamonti F, Buser AS, Teo SS, Tiedt R, Passweg JR, Tichelli A, Cazzola M, Skoda RC (2005) A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med 352:1779-1790
20. Kralovics R, Stockton DW, Prchal JT (2003) Clonal hematopoiesis in familial polycythemia vera suggests the involvement of multiple mutational events in the early pathogenesis of the disease. Blood 102:3793-3796
21. Levine RL, Wadleigh M, Cools J, Ebert BL, Wernig G, Huntly BJ, Boggon TJ, Wlodarska I, Clark JJ, Moore S, Adelsperger J, Koo S, Lee JC, Gabriel S, Mercher T, D'Andrea A, Frohling S, Dohner K, Marynen P, Vandenberghe P, Mesa RA, Tefferi A, Griffin JD, Eck MJ, Sellers WR, Meyerson M, Golub TR, Lee SJ, Gilliland DG (2005) Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell 7:387-397
22. Lichter P, Joos S, Bentz M, Lampel S (2000) Comparative genomic hybridization: uses and limitations. Semin Hematol 37:348-357
23. Messora C, Bensi L, Vecchi A, Longo R, Giacobbi F, Temperani P, Bevini M, Emilia G, Sacchi S (1994) Cytogenetic conversion in a case of polycythaemia vera treated with interferon-alpha. Br J Haematol 86:402-404
24. Najfeld V, Montella L, Scalise A, Fruchtman S (2002) Exploring polycythaemia vera with fluorescence in situ hybridization: additional cryptic 9p is the most frequent abnormality detected. Br J Haematol 119:558-566
25. Pellagatti A, Vetrie D, Langford CF, Gama S, Eagleton H, Wainscoat JS, Boultwood J (2003) Gene expression profiling in polycythemia vera using cDNA microarray technology. Cancer Res 63:3940-3944
26. Spivak JL (2002) Polycythemia vera: myths, mechanisms, and management. Blood 100:4272-4290
27. Temerinac S, Klippel S, Strunck E, Roder S, Lubbert M, Lange W, Azemar M, Meinhardt G, Schaefer HE, Pahl HL (2000) Cloning of PRV-1, a novel member of the uPAR receptor superfamily, which is overexpressed in polycythemia rubra vera. Blood 95:2569-2576
28. Westwood NB, Gruszka-Westwood AM, Atkinson S, Pearson TC (2001) Polycythemia vera: analysis of DNA from blood granulocytes using comparative genomic hybridization. Haematologica 86:464-469
29. Westwood NB, Gruszka-Westwood AM, Pearson CE, Delord CF, Green AR, Huntly BJ, Lakhani A, McMullin MF, Pearson TC (2000) The incidences of trisomy 8, trisomy 9 and D20S108 deletion in polycythaemia vera: an analysis of blood granulocytes using interphase fluorescence in situ hybridization. Br J Haematol 110:839-846
30. Wickenhauser C, Perez F, Siebolts U, Lorenzen J, Varus E, Frimpong S, Thiele J (2003) Structural, antigenetic and transcriptional characteristics in peripheral blood CD34+ progenitor cells from polycythemia vera patients: evidence for delayed determination. Int J Oncol 23:437-443
31. Wickenhauser C, Thiele J, Perez F, Varus E, Stoffel MS, Kvasnicka HM, Beelen DW, Schaefer UW (2002) Mixed chimerism of the resident macrophage population after allogeneic bone marrow transplantation for chronic myeloid leukemia. Transplantation 73:104-111